Intensive Care and Anaesthesia Department and Ventilab, Catholic University of Rome, Policlinico A. Gemelli, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anesthesia, Analgesia, Intensive Care and Emergency. Policlinico Paolo Giaccone, University of Palermo, Via del vespro 129, 90127, Palermo, Italy.
BMC Pulm Med. 2018 Apr 7;18(1):57. doi: 10.1186/s12890-018-0620-x.
To compare, in terms of patient-ventilator interaction and performance, a new nasal mask (Respireo, AirLiquide, FR) with the Endotracheal tube (ET) and a commonly used nasal mask (FPM, Fisher and Paykel, NZ) for delivering Pressure Support Ventilation (PSV) in an infant model of Acute Respiratory Failure (ARF).
An active test lung (ASL 5000) connected to an infant mannequin through 3 different interfaces (Respireo, ET and FPM), was ventilated with a standard ICU ventilator set in PSV. The test lung was set to simulate a 5.5 kg infant with ARF, breathing at 50 and 60 breaths/min). Non-invasive ventilation (NIV) mode was not used and the leaks were nearly zero.
The ET showed the shortest inspiratory trigger delay and pressurization time compared to FPM and Respireo (p < 0.01). At each respiratory rate tested, the FPM showed the shortest Expiratory trigger delay compared to ET and Respireo (p < 0.01). The Respireo presented a lower value of Inspiratory pressure-time product and trigger pressure drop than ET (p < 0.01), while no significant difference was found in terms of pressure-time product at 300 and 500 ms. During all tests, compared with the FPM, ET showed a significantly higher tidal volume (V) delivered (p < 0.01), while Respireo showed a trend toward an increase of tidal volume delivered compared with FPM.
The ET showed a better patient-ventilator interaction and performance compared to both the nasal masks. Despite the higher internal volume, Respireo showed a trend toward an increase of the delivered tidal volume; globally, its efficiency in terms of patient-ventilator interaction was comparable to the FPM, which is the infant NIV mask characterized by the smaller internal volume among the (few) models on the market.
比较新型鼻罩(Respireo,AirLiquide,FR)与气管内导管(ET)和常用鼻罩(FPM,Fisher and Paykel,NZ)在急性呼吸衰竭(ARF)婴儿模型中提供压力支持通气(PSV)时的患者-呼吸机交互和性能。
通过 3 种不同的接口(Respireo、ET 和 FPM)将主动测试肺(ASL 5000)连接到婴儿模型,通过标准 ICU 呼吸机在 PSV 下进行通气。测试肺被设置为模拟 5.5 公斤 ARF 婴儿,呼吸频率为 50 次/分钟和 60 次/分钟。未使用无创通气(NIV)模式,泄漏量接近零。
与 FPM 和 Respireo 相比,ET 显示最短的吸气触发延迟和加压时间(p < 0.01)。在测试的每个呼吸频率下,FPM 显示最短的呼气触发延迟,与 ET 和 Respireo 相比(p < 0.01)。与 ET 相比,Respireo 的吸气压力-时间乘积和触发压力下降值较低(p < 0.01),而在 300 和 500 ms 时压力-时间乘积无显著差异。在所有测试中,与 FPM 相比,ET 输送的潮气量(V)明显更高(p < 0.01),而 Respireo 输送的潮气量呈上升趋势。
与两种鼻罩相比,ET 显示出更好的患者-呼吸机交互和性能。尽管内部体积较高,但 Respireo 显示出增加输送潮气量的趋势;总体而言,其在患者-呼吸机交互方面的效率与 FPM 相当,FPM 是市场上为数不多的模型中内部体积较小的婴儿 NIV 面罩。